Ohara Pharmaceutical
11
7M
8
0.19
0.27
- Areas of investment
Summary
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Ohara Pharmaceutical, startups are often financed by Senshu Ikeda Capital, Miyako Capital, Kenshin Fujiwara. The meaningful sponsors for the fund in investment in the same round are PALTEK, Miyako Capital, Kaga Electronics.
The high activity for fund was in 2018. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Among the various public portfolio startups of the fund, we may underline Hacarus Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Life Science.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 0
- Rounds per year
- 0.19
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (5)
- Health Care (5)
- Medical (5)
- Software (4)
- Manufacturing (3) Show 12 more
- Investments by region
-
- Nigeria (2)
- Japan (6)
- Mauritius (2)
- Kenya (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Helium Health | 05 Jun 2023 | Software, Payments, Health Care, Electronic Health Record (EHR), Medical | Early Stage Venture | 30M | Lagos, Lagos, Nigeria |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.